Blood in the urine, a rising PSA value, a mass found incidentally in the kidney or a palpable hardness in the testicle does not always mean cancer. However, these findings need to be evaluated by the right specialist without delay. Urologic oncology is a specialized field of urology covering the diagnosis and treatment of cancers of the kidney, bladder, testicle, penis and upper urinary tract, above all prostate cancer, which is common in men. The main goal here is not only to control the tumor but also, whenever possible, to preserve the functions that determine quality of life, such as urinary continence, sexual function and kidney function.
A cancer diagnosis can create uncertainty for patients and their families. Yet thanks to current imaging methods, pathology evaluation, minimally invasive surgical techniques and close follow-up options, for many urologic cancers a treatment plan can be created in detail according to the stage of the disease and the individual's living conditions.
Which cancers does urologic oncology cover?
The course, treatment and follow-up needs of urologic cancers differ from one another. Prostate cancer is often investigated after an elevated PSA or an examination finding, while bladder cancer often presents with painless blood in the urine. Kidney tumors, on the other hand, are nowadays often seen incidentally on ultrasonography or computed tomography performed for another reason.
In testicular cancer, painless enlargement, hardness or a change in shape of the testicle should be taken into account. In the rarer tumors of the penis, ureter and renal pelvis, early evaluation can also be decisive in preserving an organ-sparing approach, treatment success and quality of life.
Not every mass is malignant. On the other hand, a small or asymptomatic lesion should not be assumed to be insignificant either. Proceeding with the right imaging, a biopsy when necessary and experienced pathology evaluation makes it possible both to avoid unnecessary procedures and not to delay treatment.
Which symptoms require evaluation without delay?
Visible blood in the urine, recurrent or unexplained urinary tract infections, a persistent change in urination habits, flank pain, unexplained weight loss and a palpable mass in the testicle are among the symptoms that require evaluation. Prostate cancer often does not cause symptoms in its early stages. For this reason, a PSA testing and urological examination plan should be created, taking into account age, family history and personal risks in particular.
An elevated PSA alone does not establish a cancer diagnosis. Prostate enlargement, infection, certain recent procedures and various clinical conditions can affect the PSA value. Conversely, a PSA within normal limits does not completely rule out risk in every case either. The result needs to be interpreted by looking at age, prostate volume, previous values and examination findings together.
Similarly, blood in the urine can occur due to stones, infection or benign causes. Detailed examination of the bladder and upper urinary tract is especially important in people who smoke, who are in older age groups or whose bleeding recurs.
The diagnostic process does not rely on a single test
In urologic oncology, a reliable treatment plan begins with accurate staging. In the physician's evaluation, complaints, family history, medications used, accompanying conditions and previous tests are considered together. Blood and urine tests, as well as ultrasonography, computed tomography, magnetic resonance imaging or, when necessary, advanced imaging methods such as PET may be added to the examination.
When prostate cancer is suspected, multiparametric prostate MRI can help assess the need for a biopsy more accurately. When a biopsy decision is made, targeted sampling provides important information in determining the grade of the tumor and the risk of spread. When bladder cancer is suspected, the bladder needs to be examined directly with a camera through cystoscopy. In kidney masses, the size, location and imaging characteristics of the mass and the function of the other kidney directly affect the treatment decision.
The pathology result provides guidance on the type of cancer and its degree of aggressiveness. After that, it is evaluated whether the disease is localized and whether it has spread to the lymph nodes or distant organs. The treatment option should become clear only after this comprehensive picture.
Personalized options in urologic oncology treatment
Even for cancer of the same organ, there is no single treatment method for everyone. The stage, grade and location of the tumor, the patient's age, general health, kidney function and life expectancy are evaluated together. The patient's priorities are also an integral part of this decision.
In some early-stage, low-risk prostate cancers, active surveillance may be a suitable option. This approach does not mean no treatment; it involves close monitoring of the disease with PSA, examination, imaging and, when necessary, repeat biopsies. The aim is to avoid the side effects of unnecessary treatment while intervening at the right time if signs of disease progression appear.
In patients who require surgery, open, laparoscopic or robotic techniques may be considered. In prostate cancer, radical prostatectomy involves removal of the prostate and, when necessary, the surrounding tissues. Cancer control is the priority in surgical planning; however, in suitable patients, nerve-sparing techniques may help preserve urinary continence and erectile function. However, the likelihood of preserving these functions varies according to the spread of the tumor, age, preoperative function and surgical findings.
In kidney tumors, if technically possible, partial nephrectomy, in which only the tumor is removed instead of the entire kidney, may be preferred. Especially for small and favorably located masses, this approach helps preserve kidney tissue. When the tumor is centrally located, large or extensive, it may be necessary to remove the entire kidney. Laparoscopic and robotic surgery offer the possibility of performing the procedure through smaller incisions in selected patients; still, it cannot be said that this is the most suitable method for every patient.
In bladder cancer, treatment is planned according to how far the tumor has progressed into the bladder wall. In superficial tumors, the tumor can be removed endoscopically and, when necessary, medication can be instilled into the bladder. In disease that has invaded the muscle layer, options such as removal of the bladder, reconstruction of the urinary tract, radiotherapy and systemic treatments are considered through multidisciplinary evaluation.
In testicular tumors, the initial surgical approach is usually removal of the testicle through the groin. Depending on the pathology result, active surveillance, chemotherapy, radiotherapy or additional surgical options may be determined. Especially in patients who plan to have children, discussing the option of sperm freezing before treatment can be valuable.
Experience matters as much as technology in surgical decisions
Robotic and laparoscopic surgery may offer advantages in suitable patients, such as reduced blood loss, smaller incisions and a faster return to daily life. However, the availability of technology alone is no guarantee of a good result. The surgeon's experience, anatomical assessment, the characteristics of the tumor and the quality of postoperative care determine the outcome together.
In the advanced laparoscopic and robotic surgical approach of Assoc. Prof. Dr. Uygar Miçooğulları, the decision is also made not only according to the technological aspect of the method, but by considering oncological safety, functional expectations and the patient's personal circumstances. When necessary, joint evaluation with medical oncology, radiation oncology, radiology and pathology specialists is an important part of the treatment.
Postoperative follow-up is a continuation of treatment
After urologic cancer surgery, the follow-up process is as important as the operation. The frequency of follow-up varies according to the type and stage of the cancer, the pathology result and the treatment applied. PSA monitoring, imaging studies, cystoscopy, blood tests or physical examinations may be planned at certain intervals.
During this period, topics such as urinary incontinence, erectile problems, stoma care, pain, signs of infection or psychological strain should be discussed openly. Especially after prostate surgery, pelvic floor exercises, sexual function treatments in suitable patients and regular communication support the recovery process. Answering the patient's questions in an accessible way is necessary not only for comfort, but also for the early detection of possible problems.
When a suspicious finding is detected, the right step is not to decide based on isolated comments on the internet, but to see a urology specialist who will evaluate your test results with you. An early, transparent and personalized evaluation both clarifies the treatment options and helps you regain control of the process.
